The International Academy of Clinical Research (IAoCR) has now released its draft GxP Training Guidelines for public consultation following initial review and feedback from over 35 not-for-profit and membership organisations around the world.
Over 60 training and quality assurance personnel have already requested a copy of the draft GxP Training Guidelines which are being made freely available by the IAoCR in order to involve the widest number of interested parties from within the clinical research industry.
As CEO at IAoCR, Jacqueline Johnson North explains: “We have always felt that it is crucial to engage the entire industry in order to create the most cohesive, relevant set of GxP Training recommendations possible. The more people who review this document and provide feedback, the more valuable it will be to all of us. We would like these training guidelines to be applicable to all members of the industry across all sectors and we actively encourage everyone to get involved. We are very pleased with the interest shown to date and hope this accurately reflects the level of commitment from the industry.”
Following the launch of this initiative, executives from the IAoCR have been invited to speak at a number of conferences later this year and on into 2013. Jacqueline will be speaking at the European Training Conference in Lisbon in April 2013 and the IAoCR’s Principal Director, Martin Robinson will be speaking at the French Biomedical Data Management Association conference in Paris in November 2012.
The GxP Training Guidelines have been produced by the International Academy of Clinical Research with input from an independent taskforce of industry experts from the international clinical research community. The aim of the Guidelines is to provide best practice recommendations for the training life-cycle to enable organisations to be able to demonstrate individuals’ competence. The document contains minimum requirements for best practice in training and will be used to help introduce consistent training standards across the industry. It is hoped that the guidelines will be voluntarily adopted across the industry and that this will provide a global framework for best practice.
To receive a copy of the draft Guidelines and information on how to provide feedback complete the webform on www.iaocr.com/gxpt The deadline for feedback is 30 September 2012. After this time, the guidelines will be finalised ready for publication in October 2012.
For more information, please visit www.iaocr.com.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Novel Agent Shows Superiority Over Placebo in Reducing Monthly Migraine Days
September 5th 2024Lu AG09222 shows promise as first-in-class medication that prevents neurogenic inflammation, vasodilation, and parasympathetic lacrimation, which are considered to be surrogate markers of migraine attacks.